Back to BANK OF AMERICA CORP /DE/ BANK OF AMERICA CORP /DE/

AVTXAVTX
7 quarters

Position history for BANK OF AMERICA CORP /DE/BANK OF AMERICA CORP /DE/'s holdings in AVALO THERAPEUTICS INC

BANK OF AMERICA CORP /DE/ holds 1.9M shares of AVTX (AVALO THERAPEUTICS INC), worth $35.4M as of 2026-Q2. The position was increased (+197.6% shares). AVTX represents 0.0% of BANK OF AMERICA CORP /DE/'s portfolio.

Current Value

$35.4M

Current Shares

1.9M

Total Value Change

+$35.3M

Total Shares Change

+1.9M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.9M
+197.6%
$35.4M0.0%$18.48
47
2026-Q1
Increased
643,000
+3.5%
$9.6M0.0%$18.85
29
2025-Q4
Increased
621,350
+2.6%
$11.3M0.0%$17.81
29
2025-Q3
Increased
605,842
+49.0%
$7.7M0.0%$13.02
38
2025-Q2
Increased
406,571
+7066.8%
$2M0.0%$4.78
42
2025-Q1
Increased
5,673
+0.1%
$45,4410.0%$8.46
14
2024-Q4
New
5,670
-
$42,1280.0%$7.80
31

Other major holders of AVTX: FMR LLC, BlackRock, Inc., STATE STREET CORP, FARALLON CAPITAL MANAGEMENT, L.L.C., Point72 Asset Management, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used